These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22339855)

  • 21. Barrier properties of gastrointestinal mucus to nanoparticle transport.
    Crater JS; Carrier RL
    Macromol Biosci; 2010 Dec; 10(12):1473-83. PubMed ID: 20857389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gel-forming mucin interactome drives mucus viscoelasticity.
    Demouveaux B; Gouyer V; Gottrand F; Narita T; Desseyn JL
    Adv Colloid Interface Sci; 2018 Feb; 252():69-82. PubMed ID: 29329667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
    Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
    Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin dynamics and enteric pathogens.
    McGuckin MA; Lindén SK; Sutton P; Florin TH
    Nat Rev Microbiol; 2011 Apr; 9(4):265-78. PubMed ID: 21407243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity and mucus structure and function.
    Sheehan JK; Kesimer M; Pickles R
    Novartis Found Symp; 2006; 279():155-66; discussion 167-9, 216-9. PubMed ID: 17278393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.
    Johansson ME; Phillipson M; Petersson J; Velcich A; Holm L; Hansson GC
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15064-9. PubMed ID: 18806221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier.
    Li LD; Crouzier T; Sarkar A; Dunphy L; Han J; Ribbeck K
    Biophys J; 2013 Sep; 105(6):1357-65. PubMed ID: 24047986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrier properties of mucus.
    Cone RA
    Adv Drug Deliv Rev; 2009 Feb; 61(2):75-85. PubMed ID: 19135107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions.
    Popov A
    J Ocul Pharmacol Ther; 2020; 36(6):366-375. PubMed ID: 32667250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Airway mucus: its components and function.
    Lillehoj ER; Kim KC
    Arch Pharm Res; 2002 Dec; 25(6):770-80. PubMed ID: 12510824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model.
    Teubl BJ; Absenger M; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
    Eur J Pharm Biopharm; 2013 Jun; 84(2):386-93. PubMed ID: 23291061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From mucins to mucus: toward a more coherent understanding of this essential barrier.
    Thornton DJ; Sheehan JK
    Proc Am Thorac Soc; 2004; 1(1):54-61. PubMed ID: 16113413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties.
    Boegh M; Nielsen HM
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):179-86. PubMed ID: 25349046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosomes: Intrinsically Mucoadhesive Glycosylated Mucin Nanoparticles as Multi-Drug Delivery Platform.
    Butnarasu C; Petrini P; Bracotti F; Visai L; Guagliano G; Fiorio Pla A; Sansone E; Petrillo S; Visentin S
    Adv Healthc Mater; 2022 Aug; 11(15):e2200340. PubMed ID: 35608152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.
    Delaveris CS; Webster ER; Banik SM; Boxer SG; Bertozzi CR
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12643-12650. PubMed ID: 32457151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.
    Kumari A; Pal S; G BR; Mohny FP; Gupta N; Miglani C; Pattnaik B; Pal A; Ganguli M
    Mol Pharm; 2022 May; 19(5):1309-1324. PubMed ID: 35333535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mucus and mucin--biochemical and medical problems].
    Gindzieński A; Zwierz K
    Postepy Biochem; 1991; 37(3-4):146-53. PubMed ID: 1812472
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications.
    Hansen IM; Ebbesen MF; Kaspersen L; Thomsen T; Bienk K; Cai Y; Malle BM; Howard KA
    Mol Pharm; 2017 Jul; 14(7):2359-2367. PubMed ID: 28499338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucins, Mucus, and Goblet Cells.
    Ma J; Rubin BK; Voynow JA
    Chest; 2018 Jul; 154(1):169-176. PubMed ID: 29170036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.